Can nutraceuticals assist treatment and improve covid-19 symptoms?

Viral diseases have always played an important role in public and individual health. Since December 2019, the world is facing a pandemic of SARS-CoV-2, a coronavirus that results in a syndrome known as COVID-19. Several studies were conducted to implement antiviral drug therapy, until the arrival of SARS-CoV-2 vaccines. Numerous scientific investigations have considered some nutraceuticals as an additional treatment of COVID-19 patients to improve their clinical picture. In this review, we would like to emphasize the studies conducted to date about this issue and try to understand whether the use of nutraceuticals as a supplementary therapy to COVID-19 may be a valid and viable avenue. Based on the results obtained so far, quercetin, astaxanthin, luteolin, glycyrrhizin, lactoferrin, hesperidin and curcumin have shown encouraging data suggesting their use to prevent and counteract the symptoms of this pandemic infection.

Automated summary

Viral diseases are crucial for public and individual health, and studies have shown that certain nutraceuticals may serve as supplementary therapies for improving the clinical condition of COVID-19 patients. Quercetin, astaxanthin, luteolin, glycyrrhizin, lactoferrin, hesperidin, and curcumin have demonstrated promising data, indicating their potential use for preventing and counteracting the symptoms of the pandemic infection.